Clinical trial
An Observational, Retrospective Study to Describe the Extent of Adherence to the Spanish Society of Medical Oncology Algorithm for the Treatment of Hyponatraemia Secondary to SIADH in Oncology Patients in Spain (ALGA)
NCT02548845 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Europe Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational, Retrospective Study to Describe the Extent of Adherence to the Spanish Society of Medical Oncology Algorithm for the Treatment of Hyponatraemia Secondary to SIADH in Oncology Patients in Spain (ALGA)
- Lead sponsor
- Otsuka Pharmaceutical Europe Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- June 30, 2016
- Enrollment
- 70 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hyponatremia, syndrome of inappropriate adh (siadh) secretion